DataCite Search

5 Works

FPY_20220816_OE_Visualization1.mp4

Yue Li

Media published via Optica Publishing Group

Animation of FIg. 3

1 citation

No usage information was reported.

https://doi.org/10.6084/m9.figshare.20503188 Cite

Early Itch Response with Abrocitinib is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE 3 COMPARE Trial

Adis Journals on behalf of:, Sonja Ständer, Shawn G. Kwatra, Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Gil Yosipovitch, Fan Zhang, Michael C. Cameron, Ricardo Rojo Cella, Hernan Valdez, Marco DiBonaventura & Claire Feeney

Media published via Adis Journals

Article full text The above features represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2022

1 citation

No usage information was reported.

https://doi.org/10.6084/m9.figshare.20506725.v1 Cite

FPY_20220816_OE_Visualization1.mp4

Yue Li

Media published via Optica Publishing Group

Animation of FIg. 3

No citations were reported. No usage information was reported.

https://doi.org/10.6084/m9.figshare.20503188.v1 Cite

Early Itch Response with Abrocitinib is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE 3 COMPARE Trial

Adis Journals on behalf of:, Sonja Ständer, Shawn G. Kwatra, Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Gil Yosipovitch, Fan Zhang, Michael C. Cameron, Ricardo Rojo Cella, Hernan Valdez, Marco DiBonaventura & Claire Feeney

Media published via Adis Journals

Article full text The above features represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2022

1 citation

No usage information was reported.

https://doi.org/10.6084/m9.figshare.20506725 Cite

Early Itch Response with Abrocitinib is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE 3 COMPARE Trial

Adis Journals on behalf of:, Sonja Ständer, Shawn G. Kwatra, Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Gil Yosipovitch, Fan Zhang, Michael C. Cameron, Ricardo Rojo Cella, Hernan Valdez, Marco DiBonaventura & Claire Feeney

Media published via Adis Journals

Article full text The above features represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2022

No citations were reported. No usage information was reported.

https://doi.org/10.6084/m9.figshare.20506725.v2 Cite